Phase 1 maximal-use pharmacokinetics (PK) study completed in support of planned U.S. label expansionData to complement previously announced positive Phase 3 efficacy results on extremities, neck and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results